v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

STUDY OF THE EFFECTS OF ACUTE RENAL FAILURE IN KNOWN PATIENTS CASE OF DIABETES

AUTHORS:

Dr. Zainab Zafar, Dr Huda Arshad, Dr Tehreem Hussain

ABSTRACT:

Aim: To know the results of patients with renal diabetes and acute renal failure. Place and Duration: In the Nephrology department of Services Hospital Lahore for one year duration from January 2019 to December 2019. Methods: The inclusion criteria were all adult patients who were diagnosed with type II diabetes and suspected ARF. Patients were treated conservatively or by dialysis, patients were evaluated for a total of 6 weeks, and the result was defined as complete cure, need for dialysis or mortality. Results: We conducted a study on 100 patients, 56 of whom were men and 44 women. Sepsis was the most important causative agent of ARF in 69% of patients, while urinary tract infection was the main focus in 71.2% of patients. Other ARF factors included hypovolemia (20%), cardiovascular (13.7%), acute glomerulonephritis (3.15%) and contrast exposure (2.1%). While 75 patients required dialysis in the study population, 25 patients were treated conservatively. Finally (67.39%) the patient recovered (15.21%) became dependent on dialysis and (17.39%) died. Dialysis and sepsis were used in all expired people (81.25%). Conclusion: it is well documented that patients with diabetes are prone to developing ARF and urinary tract infections are common. Patients recover with the appropriate antibiotic regimen. Patients requiring dialysis as intervention show a high level of morbidity and mortality. To avoid any avoidable cause of ARF, it is necessary to take the necessary measures to assess patients with diabetes, as this can reduce dialysis dependency and mortality. Key words: ARF, acute renal failure, diabetes, disease course

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.